Literature DB >> 29510259

Comparative transcriptomic analysis provides insights into antibacterial mechanisms of Branchiostoma belcheri under Vibrio parahaemolyticus infection.

Qi-Lin Zhang1, Qian-Hua Zhu2, Ming-Zhong Liang3, Feng Wang4, Jun Guo4, Xian-Yu Deng4, Jun-Yuan Chen5, Yu-Jun Wang6, Lian-Bing Lin7.   

Abstract

Amphioxus, a basal chordate, is widely considered to be an existing proxy of the invertebrate ancestor of vertebrates, and it exhibits susceptibility to various pathogen infections and pathogenic mimic challenges. Here, in order to understand more clearly its antibacterial mechanisms, we analyzed the ribosomal RNA (rRNA)-depleted transcriptome of Chinese amphioxus (Branchiostoma belcheri) infected with Vibrio parahaemolyticus (V. p.) via next-generation deep sequencing technology (RNA-seq). We identified a total of 3214 differentially expressed genes (DEGs) by comparing V. p.-infected and control transcriptome libraries, including 2219 significantly up-regulated and 995 significantly down-regulated DEGs in V. p.-infected amphioxus. The DEGs with the top 10 most dramatic expression fold changes after V. p. infection, as well as 53 immune-related DEGs (IRDs) belonging to four primary categories of innate immunity were analyzed further. Through gene ontology (GO) and pathway enrichment analysis, DEGs were found to be primarily related to immune processes, apoptosis, catabolic and metabolic processes, binding and enzyme activity, while pathways involving bacterial infection, immune signaling, immune response, cancer, and apoptosis were overrepresented. We validated the RNA-seq results by detecting the expression levels of 10 IRDs using qRT-PCR, and we surveyed the dynamic variation in gene expression for these IRDs at 0, 6, 12, 24, and 48 h after V. p. TREATMENT: Subsequently, according to the RNA-seq results, the presence of a primitive Toll-like receptor (TLR)-mediated antibacterial immune signaling pathway was predicted in B. belcheri. This study provides valuable information regarding antibacterial immunity for further research into the evolution of immunity in vertebrates and broadens our understanding of the innate immune response against bacterial invasion in amphioxus.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Branchiostoma belcheri; Differential expressed genes; RNA-seq; Vibrio parahemolyticus; qRT-PCR

Mesh:

Year:  2018        PMID: 29510259     DOI: 10.1016/j.fsi.2018.03.007

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  5 in total

1.  Biocontrol and Action Mechanism of Bacillus subtilis Lipopeptides' Fengycins Against Alternaria solani in Potato as Assessed by a Transcriptome Analysis.

Authors:  Dai Zhang; Ran Qiang; Zhijun Zhou; Yang Pan; Shuiqing Yu; Wei Yuan; Jianing Cheng; Jinhui Wang; Dongmei Zhao; Jiehua Zhu; Zhihui Yang
Journal:  Front Microbiol       Date:  2022-05-11       Impact factor: 6.064

2.  Transcriptomic profiling of cotton Gossypium hirsutum challenged with low-temperature gradients stress.

Authors:  Zhi-Bo Li; Xiao-Yan Zeng; Jian-Wei Xu; Rui-Hai Zhao; Yi-Nong Wei
Journal:  Sci Data       Date:  2019-10-09       Impact factor: 6.444

3.  Gene expression kinetics of Exaiptasia pallida innate immune response to Vibrio parahaemolyticus infection.

Authors:  François Seneca; David Davtian; Laurent Boyer; Dorota Czerucka
Journal:  BMC Genomics       Date:  2020-11-09       Impact factor: 3.969

4.  Integrative analyses of mRNA and microRNA expression profiles reveal the innate immune mechanism for the resistance to Vibrio parahaemolyticus infection in Epinephelus coioides.

Authors:  Xifeng Qiao; Yuyou Lu; Jiachang Xu; Niuniu Deng; Wenjie Lai; Ziyi Wu; Haoran Lin; Yong Zhang; Danqi Lu
Journal:  Front Immunol       Date:  2022-08-19       Impact factor: 8.786

5.  Evaluation of IL-17D in Host Immunity to Group A Streptococcus Infection.

Authors:  Allen Washington; Nissi Varki; J Andrés Valderrama; Victor Nizet; Jack D Bui
Journal:  J Immunol       Date:  2020-10-19       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.